ESTA logo

ESTABLISHMENT LABS HOLDINGS

ESTANASDAQ
πŸ† #2035 by market capEarnings Nov 3US Equity
$63.63β–Ό $1.69 (βˆ’2.65%)
Market closed Β· at close
πŸ””
Track ESTA
Get earnings, price moves & breaking news on Telegram
Track
24hβ–Ό 2.6%
7dβ–Ό 6.1%
14dβ–Ό 10.2%
30dβ–Ό 8.4%
ytdβ–Ό 12.9%
1yβ–² 55.3%
🏦Market Cap
$1.87B
Small Cap
πŸ“ˆRevenue Growth (YoY)
+27.1%
High Growth
πŸ“ŠGross Margin
70.5%
High
πŸ’΅FCF Margin
-17.1%
Thin
βš–οΈP/S Ratio
7.6x
Fair
Otter Score
56
Weak

Trading Snapshot

Day Range
$63.24 – $64.89
52-Week Range
$38.38 – $97.59
Volume
$2.12B
Avg Volume
$2.70B
Shares Outstanding
29.4M
Next Earnings
Nov 26, 2026

Fundamentals Snapshot

Annual Revenue
$211M
Last Q Revenue
$68M
P/E Ratio
-48.7
P/S Ratio
7.6x
EPS (TTM)
$-1.29
Dividend Yield
0.00%
Dilution (1yr)
+2.3%

Why Investors Own ESTA

  • βœ“High-growth profile β€” revenue up +13.2% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 28% gross margin and 28% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

ESTA logo

ESTABLISHMENT LABS HOLDINGS

ESTA
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$211Mβ–² +27.1% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
69.3%β–² +5.1% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
βˆ’$39Mβ–Ό βˆ’22.0% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
βˆ’$58Mβ–Ό βˆ’22.2% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
29.6Mβ–² +2.3% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$189Mβ–Ό βˆ’$54M YoY
StockOtter Β· stockotter.space

About ESTABLISHMENT LABS HOLDINGS

Establishment Labs Holdings Inc. operates as a medical technology enterprise specializing in the creation and commercialization of devices for aesthetic and reconstructive plastic surgery. The company is primarily recognized for its silicone gel-filled breast implants, sold under the Motiva Implants brand. Among these are the Motiva Ergonomix and Motiva Ergonomix2, which are distinctive, gravity-sensitive, round, soft silicone-gel-filled implants. Furthermore, Establishment Labs provides the Motiva Flora Tissue Expander for breast tissue and distributes the Puregraft range of products, utilized for the harvesting and redistribution of autologous adipose tissue. The firm markets its offerings across Europe, Latin America, the Asia-Pacific region, and other global markets, leveraging both a direct sales force and exclusive distributors. Founded in 2004, Establishment Labs has its main office situated in Alajuela, Costa Rica.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
56/100

Analyst Price Target

β“˜
Average Target
$69.21
β–² +8.8% Upside
High Target$75.67
Low Target$62.91
Based on 37 analysts

Latest News & Updates